Form D · Biotechnology
Singulex, Inc.
Alameda, CA · CIK 0001323620
Offering snapshot reported Jun 7, 2013 · SEC filing
- Reported sold
- $12.2M Offering amount: $20.1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 17, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2013 | Initial | $12,189,449 | No comparison | 6 | SEC filing |
| Mar 15, 2012 | Initial | $15,335,540 | No comparison | 8 | SEC filing |
| Aug 5, 2011 | Amendment | $9,651,335 | $2,175,822vs May 23, 2011 | 8 | SEC filing |
| May 23, 2011 | Initial | $7,475,513 | No comparison | 3 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 15, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 9, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-197624
The total amount sold includes the value of securities issued upon conversion of promissory notes.
Series G Preferred Stock; Common Stock issuable upon conversion thereof; Warrants to purchase shares of Common Stock; Common Stock issuable upon exercise of the warrants.
Source: Form D, filed Jun 7, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guido Baechler | Director, Executive |
| Michael Bell | Executive |
| Heiner Dreismann | Director |
| Philippe J. Goix | Director |
| Carl L. Gordon | Director |
| Hironori Hozoji | Director |
| Gregory R. Johnson | Director |
| Andre Marion | Director |
| R. Douglas Norby | Director |
| Stephen L. Rose | Director |
| Fred K. Vogt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1701 Harbor Bay Parkway Suite 200
Alameda, CA, 94502
Alameda, CA, 94502